Images in pathology: birefringent cryptococcus.
Yoo
Simon S
SS
Division of Dermatopathology, Department of Dermatology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Viglione
Michael
M
Barrett
Terry
T
D000666:Amphotericin B / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001718:Birefringence; D002481:Cellulitis / Q000382:microbiology* / Q000473:pathology; D003453:Cryptococcosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003454:Cryptococcus / Q000302:isolation & purification*; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D012867:Skin / Q000382:microbiology / Q000473:pathology
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole; D011241:Prednisone